Skip to main content

Pharmacology Essentials: Mechanisms, Indications, and Toxicities

A structured overview of critical pharmacological classes, including cytotoxic agents, antimetabolites, anti-inflammatory drugs, and antihistamines, detailing their mechanisms of action, clinical indications, and potential toxicities for healthcare students.

Save this reading to your study set

Sign up free

Pharmacology is a vast field that requires understanding not just what a drug does, but how it interacts with cellular machinery to produce a therapeutic effect. For healthcare students, the key to mastering this subject is linking a drug's mechanism of action (MOA) to its clinical indication and its potential toxicities. This article provides a structured overview of several critical pharmacological classes, ranging from potent cytotoxic agents used in oncology to common anti-inflammatory medications.

Cytotoxic Agents and Antimetabolites

In oncology, drugs are classified by how they interfere with the cell cycle. Because cancer cells divide rapidly, they are particularly susceptible to agents that disrupt DNA replication or cell division.

Alkylating Agents and Antimetabolites

Alkylating agents, such as Cyclophosphamide, are considered cell cycle non-specific. They work by cross-linking and damaging DNA, which prevents the replication of malignant cells or rapidly dividing immune cells. A major clinical concern with cyclophosphamide is myelosuppression (a decrease in bone marrow activity) and the risk of hemorrhagic cystitis.

Antimetabolites (e.g., Methotrexate, 5-fluorouracil) are S-phase specific. They act as "imposters," blocking the substances required for DNA and RNA synthesis. Because they target the synthesis phase, they are highly effective against rapidly dividing cells but can cause significant side effects like mucositis and GI toxicity.

This diagram illustrates the cell cycle, including the M, G1, S, and G2 phases, and explains how antimetabolites inhibit DNA/RNA synthesis during the S-phase, leading to S-phase arrest.
This diagram illustrates the cell cycle, including the M, G1, S, and G2 phases, and explains how antimetabolites inhibit DNA/RNA synthesis during the S-phase, leading to S-phase arrest.

Antitumour Antibiotics and Mitotic Inhibitors

Antitumour antibiotics like Doxorubicin disrupt DNA function directly. While highly effective, they carry a significant risk of cardiotoxicity, necessitating ongoing cardiac assessment for patients on this regimen.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.